New drug study aims to control rare genetic tumor disorder
Disease control
Recruiting now
This study is testing how well the drug belzutifan works for controlling tumors in people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition that causes tumors in multiple organs. Researchers will follow 100 patients in Brazil to see how effectively the drug shrinks …
Phase: PHASE2 • Sponsor: José Claudio Casali da Rocha • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC